Alder Biochem Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 07-07-2024
- Paid Up Capital ₹ 10.00 Cr
as on 07-07-2024
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 36.45 Cr
as on 07-07-2024
- Revenue 7192.43%
(FY 2023)
- Profit -89073.88%
(FY 2023)
- Ebitda -11668.58%
(FY 2023)
- Net Worth -147.77%
(FY 2023)
- Total Assets -1.17%
(FY 2023)
About Alder Biochem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 10.00 Cr.
The company currently has active open charges totaling ₹36.45 Cr.
Rajneesh Singhal and Abhishek Singhal serve as directors at the Company.
- CIN/LLPIN
U74999UR2016PTC007348
- Company No.
007348
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Oct 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Alder Biochem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajneesh Singhal  | Director | 04-Oct-2016 | Current |
| Abhishek Singhal | Director | 04-Oct-2016 | Current |
Financial Performance of Alder Biochem.
Alder Biochem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 7192.43% increase. The company also saw a substantial fall in profitability, with a 89073.88% decrease in profit. The company's net worth observed a substantial decline by a decrease of 147.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alder Biochem?
In 2022, Alder Biochem had a promoter holding of 33.33% and a public holding of 66.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Himshikha Infrastructure Private LimitedActive 19 years 3 monthsRajneesh Singhal and Abhishek Singhal are mutual person
Aven Foods Private LimitedActive 9 years 7 monthsRajneesh Singhal and Abhishek Singhal are mutual person
- Value Plus Life Sciences Private LimitedActive 18 years 3 months
Rajneesh Singhal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Nov 2021 | ₹5.19 Cr | Open |
Others Creation Date: 30 Mar 2021 | ₹2.00 Cr | Open |
Others Creation Date: 30 Mar 2021 | ₹6.09 M | Open |
How Many Employees Work at Alder Biochem?
Alder Biochem has a workforce of 126 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alder Biochem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alder Biochem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
